deltatrials
Recruiting PHASE2 INTERVENTIONAL 1-arm NCT01656603

Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation

A Multicenter Safety Study of Unlicensed, Investigational Cryopreserved Cord Blood Units Manufactured by the National Cord Blood Program and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients

Sponsor: New York Blood Center

Conditions Infusion Reactions
Interventions unlicensed CBU
Updated 17 times since 2017 Last updated: Apr 17, 2024 Started: Feb 29, 2012 Primary completion: Dec 31, 2025 Completion: Dec 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Infusion Reactions and is currently actively recruiting participants. New York Blood Center leads this study, which shows 17 recorded versions since 2012 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~May 2017 · 3 months · monthly snapshot~May 2017 – ~Jun 2018 · 13 months · monthly snapshot~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshot~Dec 2018 – ~Mar 2020 · 15 months · monthly snapshot~Mar 2020 – ~Jun 2020 · 3 months · monthly snapshot~Jun 2020 – ~Jul 2020 · 30 days · monthly snapshot~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Apr 2022 · 13 months · monthly snapshot~Apr 2022 – ~May 2022 · 30 days · monthly snapshot~May 2022 – ~Apr 2023 · 11 months · monthly snapshot~Apr 2023 – ~May 2024 · 13 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 11 months · monthly snapshot

Change History

17 versions recorded

  1. Sep 2025 — Present [monthly]

    Recruiting PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Recruiting PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

  4. May 2024 — Jul 2024 [monthly]

    Recruiting PHASE2

  5. Apr 2023 — May 2024 [monthly]

    Recruiting PHASE2

▶ Show 12 earlier versions

  1. May 2022 — Apr 2023 [monthly]

    Recruiting PHASE2

  2. Apr 2022 — May 2022 [monthly]

    Recruiting PHASE2

  3. Mar 2021 — Apr 2022 [monthly]

    Recruiting PHASE2

  4. Jan 2021 — Mar 2021 [monthly]

    Recruiting PHASE2

  5. Jul 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  6. Jun 2020 — Jul 2020 [monthly]

    Recruiting PHASE2

  7. Mar 2020 — Jun 2020 [monthly]

    Recruiting PHASE2

  8. Dec 2018 — Mar 2020 [monthly]

    Recruiting PHASE2

  9. Jun 2018 — Dec 2018 [monthly]

    Recruiting PHASE2

  10. May 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  11. Feb 2017 — May 2017 [monthly]

    Recruiting PHASE2

  12. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Feb 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • New York Blood Center
Data source: New York Blood Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Akron, United States , Atlanta, United States , Aurora, United States , Bethesda, United States , Birmingham, United States , Boston, United States , Charleston, United States , Charlottesville, United States , Chicago, United States , Cincinnati, United States and 45 more locations